Upregulation of ANP32B promoted CRC cell amplification and migration, whereas inhibition of ANP32B suppressed CRC cell progression, indicating that ANP32B functions as an oncogene in CRC. The gene discussed is ANP32B; the disease is colorectal carcinoma.